锦欣生殖：截至2025年6月30日止六个月的业绩公告
1951Jinxin Fertility Group Limited* 20256 30 20256301,288.620246301,443.810.7% 20256301,044.12024630190.320256301,039.92024630189.7 2025630(1)82.32024630259.668.3%2025630EBITDA(2)938.22024630EBITDA380.92025630EBITDA(3)224.72024630EBITDA418.146.3% 20256300.392025630(4)0.03 20256302024630 EBITDAEBITDA (1)(i)(ii)(iii)(iv)(v)IOT(vi) (2)EBITDA (3)EBITDAEBITDA(i)(ii)(iii)(iv)IOT (4) 2025630 20256302024 (1,106,338)209,269 63020252024 — (1,039,916)189,682(4,204)631 (1,044,120)190,313 — (1,101,608)208,396(4,730)873 — (1,106,338)209,269 202563020241231 202563020241231 9,253,92510,354,187 20256 30 (a)10%50% (b)202463020225,000,00012,644,000 20256 30 63020252024 63020252024 679,650695,491 679,650517,321–178,170 679,650695,491 2025630 1. 201853221961320182019625 (i)(ii)(iii)(iv)(v) 34 2025630147,853,000750,552,000464,009,000 2025630491,538,0002025630350,000,000 2025630 2025630 2. 2025630202412 31 202511 21 3. 20252024630 202520246308 2025630 20256309,042,821,0003,477,275,000202412319,070,095,0004,362,767,000202563020241231 10% 63020252024 Huntington Reproductive Center Medical GroupHRC Medical 4. 5. 50,000,00020246302024119 6. 202161550,000,000202551525,000,00020,000,0002024630202445,000,000 8. 202520246 30 9. 10. 2025202463016.5% 2025202463021%8.84%20252024630 25%15%20081 110% 11. 2024630202312315.955150,000,000202320246 25 20256302024630 12. 20256302025630 2024630 13. 124,660,000202463067,056,000 1201261262024630113,999,0002024630113,999,00020246 30 14. 20242024 HRC ManagementHRC Management729IVFHRC ManagementHRC Management952,413,0002024630HRC Management631,594,000320,819,000HRC Management215,556,000105,263,00020246302025630HRC Management2,148,983,000 HRC Management202563017.8%22.6%10.9%202417.8%26.8%13.1%HRC Management20256307.9%7.6%20246.0%4.0%3%20243% 40,166,0002024630 15. 20241231202563048,627,0002024630202563035,676,000202484,303,000 3,172,00022,708,00020243,115,00022,391,000IVFUniversal, LLC1,014,0007,257,0002024938,0006,742,000202612312026123120242026123120261231 3090202490 HRC Management60365 60180 9091180180 (i)202224202563020241231 (ii) 3090 18. 20256301,695,513,00020246301,421,692,0001,604,545,00020246301,526,097,00020256302.15%5.9%202412312.5%7.3%202520342024123120252034 202521475,000,000536,895,000550,000,000549,395,000202563063,841,000466,089,000550,000,0001.55%1.25%182430365%5%5%85% 207020902,5002016201420162016201620231,500900200020151,60020252040 20162023ARS36%33%202319% 202522820242024(i)20241,408.32023139(ii)20249542023526.77‰(iii)20241,0937.76‰(iv)2024-0.99‰2021 2021732023959.6316.51500320247 2022820253312024 20241041320241127202412112025 2025 202537 202531310,00050,000100,000 20257202511332025113 ——IOTMSAIOT/MSA (1)IOT/MSAIOT/MSA2025630252.72024630287.4 (2) 20246307,5716.1%20256307,111IUIIUI20246302272025630969IUIOPU 20241,5002024IVF70 20||IVF+MDTVIP2025630VIP20.8% 20246303,02216.0%20256302,539IUIIUI20246302232025630894IUIOPU IVFVIP IUIIUI20%IVF 20246302,1333.5%20256302,0592025630 IVFIVFEmbryo GlueAI78.5% PRPIVFIVF145% HRC Medical202520246302,2588.9%20256302,058—(SB729)— HRC Medical 372Denovo20257HRC Medical202530HRC Medical202520259HRC Medical 2025HRC MedicalHRC Medical HRC Medical20252021(USC)HRC MedicalUSC IVF/ICSIIVF/ICSI80%3,000IVF/ICSI20%2027402.8PT Morula IndonesiaMorula40%ARS 50%80% IPIP (i) (in vitro activation, IVA)(Platelet-Rich Plasma, PRP)(ii)(iii)(iv)(v) (AI)CD138+ 2025 20253312024 0 IVF HRC Medical15%SB7292026120203-53 HRC Medical372025 20247Jinxin Life Asia Healthcare Investment Group Pte.Ltd.Morula30%MorulaIT IVF2025 (i)(ii) 202220222172024625(i)(ii)(iii)20222024531 HRC ManagementHRC ManagementIVF3IVFHRC Medical (ESG) ESGESGESG2025 20246301,443.810.7%20256301,288.6(i) ARS87.3(ii)34.7(iii)17.4(iv)3.6(v)19.3(a) OPU8.3%ARSIUIIVF80%85%10.04%7%8%ARS(b)24%(c) 2024630860.74.2%2025630897.221.1HRC Medical4 2024630583.032.9%2025630391.4202463040.4%202563030.4% 202463026.551.7%202563012.813.0 0.68,650%52.550 20256307.820246303.8 202463010.917.4%20256309.0 202463086.314.5%202563073.8 2024630215.71.5%2025630219.0 202463028.551.2%202563043.1202563049.8202463067.4 202463075.4202563044.489.845.439.8% 20251,044.12024190.3(i)(ii)(iii)IOT (iv)(i)IUIIVF(ii)(iii)2025 EBITDAEBITDA 2024630259.668.3%202582.3 EBITDA2024630418.146.3%2025224.7 20252024630 EBITDA (1) (2) (3)HRC Medical729(SB729)IVFIVF (4)(i)(ii)(iii) (5)IOT (6) 2024123150.99.2%202563046.2 20241231322.36.4%2025630301.6 20241231737.81.7%2025630750.6 201962,808.1202121,253.52021300202232023156.725175,000,0001,161.6999.0202311620251,695.5202563050,0005,000,000,000202563033.9%66.1%2024123130.8%69.2% 2025630 20256302,367.6202412312,270.1 2025630 2025630 2025630 100%202563016.9%2024123115.1% 20256303,3653,0373282025630396.72024630371.5 202220222172024625202220245312024630 20256302024630 C1 2025630 C32025630 2,808.12025630 2025630 (1)(i) 20.0%561.6(a)(b)(c)(ii) 5.0%140.
